Cardinal Health Beheer

Beheer criteriumcontroles 2/4

De CEO Cardinal Health's is Jason Hollar, benoemd in Sep2022, heeft een ambtstermijn van 2.08 jaar. De totale jaarlijkse vergoeding van { bedraagt $ 25.65M, bestaande uit 5.6% salaris en 94.4% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 0.008% van de aandelen van het bedrijf, ter waarde $ 2.02M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 2.1 jaar en 3.1 jaar.

Belangrijke informatie

Jason Hollar

Algemeen directeur

US$25.7m

Totale compensatie

Percentage CEO-salaris	5.6%
Dienstverband CEO	2.1yrs
Eigendom CEO	0.008%
Management gemiddelde ambtstermijn	2.1yrs
Gemiddelde ambtstermijn bestuur	3.1yrs

Recente managementupdates

Recent updates

Analyse CEO-vergoeding

Hoe is Jason Hollar's beloning veranderd ten opzichte van Cardinal Health's winst?
Datum	Totale vergoeding	Salaris	Bedrijfswinsten
Jun 30 2024	US$26m	US$1m	US$852m
Mar 31 2024	n/a	n/a	US$552m
Dec 31 2023	n/a	n/a	US$639m
Sep 30 2023	n/a	n/a	US$156m
Jun 30 2023	US$19m	US$1m	US$330m
Mar 31 2023	n/a	n/a	US$463m
Dec 31 2022	n/a	n/a	-US$1b
Sep 30 2022	n/a	n/a	-US$1b
Jun 30 2022	US$4m	US$729k	-US$938m
Mar 31 2022	n/a	n/a	-US$955m
Dec 31 2021	n/a	n/a	US$555m
Sep 30 2021	n/a	n/a	US$1b
Jun 30 2021	US$4m	US$700k	US$611m
Mar 31 2021	n/a	n/a	US$1b
Dec 31 2020	n/a	n/a	US$1b
Sep 30 2020	n/a	n/a	US$973m
Jun 30 2020	US$4m	US$124k	-US$4b

Compensatie versus markt: De totale vergoeding ($USD 25.65M ) Jason } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de UK markt ($USD 5.83M ).

Compensatie versus inkomsten: De vergoeding van Jason is het afgelopen jaar met meer dan 20% gestegen.

CEO

Jason Hollar (51 yo)

2.1yrs

Tenure

US$25,650,709

Compensatie

Mr. Jason M. Hollar has been Chief Executive Officer of Cardinal Health, Inc. since September 01, 2022. He serves as Director at Cardinal Health, Inc. from August 11, 2022 and had been Chief Financial Offi...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Jason Hollar	CEO & Director	2.1yrs	US$25.65m	0.0075% $ 2.0m
Aaron Alt	Chief Financial Officer	1.7yrs	US$6.84m	0.0013% $ 341.9k
Jessica Mayer	Chief Legal & Compliance Officer	5.6yrs	US$4.66m	0.011% $ 2.9m
Stephen Mason	Chief Executive Officer of Medical Segment	5.2yrs	US$7.34m	0% $ 0
Deborah Weitzman	Chief Executive Officer of Pharmaceutical & Specialty Solutions Segment	2.1yrs	US$5.09m	0.0083% $ 2.3m
Mary Scherer	Senior VP & Chief Accounting Officer	2.1yrs	geen gegevens	0.0051% $ 1.4m
Michelle Greene	Executive VP	2.2yrs	geen gegevens	0.0080% $ 2.2m
Matt Sims	Vice President of Investor Relations	no data	geen gegevens	geen gegevens
Ola Snow	Chief Human Resources Officer	6yrs	geen gegevens	0.011% $ 3.1m
Craig Cowman	Executive Vice President of Biopharma Solutions & Strategic Sourcing	no data	geen gegevens	geen gegevens
Patricia English	Senior Vice President	1.7yrs	US$1.26m	0.0020% $ 553.6k
Ben Brinker	President of Global Products & Supply Chain	3.6yrs	geen gegevens	geen gegevens

2.1yrs

Gemiddelde duur

53yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van 0HTG wordt beschouwd als ervaren (gemiddelde ambtstermijn 2.1 jaar).

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Jason Hollar	CEO & Director	2.2yrs	US$25.65m	0.0075% $ 2.0m
Gregory Kenny	Independent Non-Executive Chairman	17.2yrs	US$570.10k	0% $ 0
Christine Ann Mundkur	Independent Director	2.1yrs	US$318.09k	0% $ 0
Patricia Hemingway Hall	Independent Director	11.1yrs	US$338.09k	0.0045% $ 1.2m
David Evans	Independent Director	4.3yrs	US$320.09k	0% $ 0
Sheri Edison	Independent Director	4.1yrs	US$338.09k	0.0017% $ 455.9k
Nancy Killefer	Independent Director	9.1yrs	US$330.61k	0% $ 0
Akhil Johri	Independent Director	6.7yrs	US$345.09k	0% $ 0
Sujatha Chandrasekaran	Independent Director	2.1yrs	US$320.09k	0% $ 0
Steven Barg	Independent Director	2.1yrs	US$318.09k	0.0011% $ 312.1k
Robert Azelby	Independent Director	less than a year	US$182.66k	0% $ 0
Michelle Brennan	Independent Director	2.1yrs	US$318.09k	0.0014% $ 371.8k

3.1yrs

Gemiddelde duur

61yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van 0HTG wordt beschouwd als ervaren (gemiddelde ambtstermijn 3.1 jaar).

Cardinal Health Beheer

Beheer criteriumcontroles 2/4

Belangrijke informatie

Recente managementupdates

Cardinal Health, Inc., Annual General Meeting, Nov 06, 2024

Cardinal Health, Inc. Announces Board Changes

CEO & Director recently sold US$8.0m worth of stock

Cardinal Health, Inc. Elects Robert "Bob" Azelby as Independent Director, Effective March 1, 2024

Cardinal Health, Inc., Annual General Meeting, Nov 15, 2023

Chief Legal & Compliance Officer recently sold US$3.5m worth of stock

Recent updates

Cardinal Health, Inc. to Report Q1, 2025 Results on Nov 01, 2024

Upcoming dividend of US$0.51 per share

Cardinal Health, Inc., Annual General Meeting, Nov 06, 2024

Cardinal Health, Inc. Announces Board Changes

CEO & Director recently sold US$8.0m worth of stock

Fourth quarter dividend of US$0.51 announced

Cardinal Health Approves Quarterly Dividend, Payable on October 15, 2024

Full year 2024 earnings released: EPS: US$3.48 (vs US$1.00 in FY 2023)

Cardinal Health, Inc. Provides Earnings Guidance for the Fiscal Year 2025

Cardinal Health, Inc. to Report Q4, 2024 Results on Aug 14, 2024

Third quarter dividend increased to US$0.51

Cardinal Health Board of Directors Approves Increase to Quarterly Dividend, Payable on July 15, 2024

Cardinal Health, Inc. Reports Impairment Charges for the Third Quarter Ended March 31, 2024

Third quarter 2024 earnings released: EPS: US$1.06 (vs US$1.35 in 3Q 2023)

Cardinal Health, Inc. to Report Q3, 2024 Results on May 02, 2024

Upcoming dividend of US$0.50 per share

Cardinal Health, Inc. Elects Robert "Bob" Azelby as Independent Director, Effective March 1, 2024

Second quarter dividend of US$0.50 announced

Cardinal Health Approves Quarterly Dividend, Payable on April 15, 2024

Second quarter 2024 earnings released: EPS: US$1.44 (vs US$0.50 loss in 2Q 2023)

Cardinal Health, Inc. (NYSE:CAH) entered into a definitive agreement to acquire Specialty Networks, LLC for $1.2 billion.

Cardinal Health, Inc. Provides Earnings Guidance for the Year 2024

Upcoming dividend of US$0.50 per share at 2.0% yield

Cardinal Health, Inc. Approves Quarterly Dividend, Payable on January 15, 2024

Cardinal Health Launches Smartgown™ Edge Breathable Surgical Gown with Assist™ Instrument Pockets

First quarter 2024 earnings released: EPS: US$0.02 (vs US$0.41 in 1Q 2023)

Cardinal Health Launches Kangaroo OMNI Enteral Feeding Pump

Cardinal Health, Inc., Annual General Meeting, Nov 15, 2023

Cardinal Health, Inc. to Report Q1, 2024 Results on Nov 03, 2023

Upcoming dividend of US$0.50 per share at 2.3% yield

Chief Legal & Compliance Officer recently sold US$3.5m worth of stock

Cardinal Health, Inc. Reiterates Earnings Guidance for the Fiscal Year 2024

Full year 2023 earnings released: EPS: US$1.00 (vs US$3.34 loss in FY 2022)

Cardinal Health Approves Quarterly Dividend, Payable on October 15, 2023

Transaction Data Systems, Inc. completed the acquisition of Outcomes Inc from Cardinal Health.

Transaction Data Systems, Inc. completed the acquisition of Outcomes Inc from Cardinal Health.

Cardinal Health, Inc. to Report Q4, 2023 Results on Aug 15, 2023

Upcoming dividend of US$0.50 per share at 2.2% yield

Cardinal Health, Inc. (NYSE:CAH) announces an Equity Buyback for $3,500 million worth of its shares.

Transaction Data Systems, Inc. agreed to acquire Outcomes business of Cardinal Health.

Cardinal Health Launches Modern Commerce Solutions for Retail Independent Pharmacies Powered by Square

Cardinal Health, Inc. Announces Quarterly Dividend, Payable on July 15, 2023

Third quarter 2023 earnings released: EPS: US$1.35 (vs US$5.06 loss in 3Q 2022)

Upcoming dividend of US$0.50 per share at 2.9% yield

Cardinal Health, Inc. Approves Quarterly Dividend, Payable on April 15, 2023

Cardinal Health, Inc. Revises Earnings Guidance for the Fiscal Year 2023

Second quarter 2023 earnings released: US$0.50 loss per share (vs US$0.18 profit in 2Q 2022)

Cardinal Health, Inc. to Report Q2, 2023 Results on Feb 02, 2023

Upcoming dividend of US$0.50 per share

Cardinal Health, Inc Announces Executive Changes, Effective February 10, 2023

Insider recently sold US$3.6m worth of stock

Cardinal Health Announces the Launch of Velocare

Insider recently sold US$3.6m worth of stock

Cardinal Health, Inc. Approves Quarterly Dividend, Payable on January 15, 2023

First quarter 2023 earnings released

Cardinal Health, Inc., Annual General Meeting, Nov 09, 2022

Cardinal Health, Inc. to Report Q1, 2023 Results on Nov 04, 2022

Upcoming dividend of US$0.50 per share

Cardinal Health Announces Executive Changes

Cardinal Health, Inc. Announces Executive Appointments

High number of new directors

Full year 2022 earnings released: US$3.34 loss per share (vs US$2.09 profit in FY 2021)

Cardinal Health Approves Quarterly Dividend, Payable on October 15, 2022

Cardinal Health Appoints Michelle Greene as Chief Information Officer

Cardinal Health, Inc. (NYSE:CAH) acquired Bendcare CPO-GPO entity from Bendcare.

Cardinal Health, Inc. (NYSE:CAH) acquired Bendcare CPO-GPO entity from Bendcare.

Cardinal Health, Inc.(NYSE:CAH) dropped from Russell 3000E Growth Index

Upcoming dividend of US$0.50 per share

Cardinal Health Approves Quarterly Dividend, Payable on July 15, 2022